56 results
Page 2 of 3
6-K/A
EX-99.2
1px41zm
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K/A
EX-99.1
ef6lmmdgn yx0i8
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
afwy 49imj
16 Sep 20
Enlivex Announces Allowance of New Chinese Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
gjm sgn4ft3cix
25 Aug 20
Enlivex Announces Allowance of New U.S. Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
eerqqj
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.2
681bqdlh0u6sxo 7g
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
o36s6ve6iamm120qd34
18 Jun 20
Enlivex Announces Allowance of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
8:32am
6-K
EX-99.1
kdef03di visu
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
v36fpa4yns5
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
yq32zdbnp
18 May 20
Condensed Consolidated Financial Statements
4:30pm
424B5
sys 6ks7t
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
3h3nb mmnn5z08
26 Feb 20
Prospectus supplement for primary offering
8:23am
6-K
EX-99.1
gmfe v2xq
24 Feb 20
Report of Foreign Private Issuer
6:30am
424B5
g2vl38fah9
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.2
p7ujgque7bx
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.1
20cuv0s0
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.1
yrdw uc1i3d0s9
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
jshhytalcsxe
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm